Cargando...
From palliative to curative treatment - stage IV mucinous adenocarcinoma, successfully treated with metronomic capecitabine in combination with Bevacizumab and surgery- a case report
BACKGROUND: Mucinous adenocarcinoma (MAC) represents 6-19 % of all colorectal carcinoma. It is associated with poorer response to chemotherapy and chemoradiotherapy. CASE PRESENTATION: A 27-year-old Swedish woman presented with stomach pain and weight loss, and was diagnosed with locally advanced MA...
Guardado en:
Publicado en: | BMC Cancer |
---|---|
Autores principales: | , , , , , , |
Formato: | Artigo |
Lenguaje: | Inglês |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4640161/ https://ncbi.nlm.nih.gov/pubmed/26555668 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1908-3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|